Skip to main content
. 2022 Sep 15;13:951065. doi: 10.3389/fpsyt.2022.951065

Table 1.

Demographic characteristics, co-occurring disorders, and frequency of outcomes in study groups.

Study group
Antidepressanta Non-antidepressant 1b Non-antidepressant 2c
n = 500 n = 573 n = 593
Demographic characteristics
Age, median (IQR) y 71 (60, 82) 71 (58, 80) 71 (59, 80)
Sex
Female, No. (%) 284 (56.8) 297 (51.8) 316 (53.3)
Male, No. (%) 216 (43.2) 276 (48.2) 277 (46.7)
Race
White, No. (%) 390 (78.0) 397 (69.3) 413 (69.7)
African American, No. (%) 45 (9.0) 57 (10.0) 54 (9.1)
Asian American or Pacific Islander, No. (%) 9 (1.8) 13 (2.3) 22 (3.7)
Other or not recorded, No. (%) 56 (11.2) 106 (18.4) 104 (17.5)
Ethnicity
Non-Hispanic, No. (%) 413 (82.6) 435 (75.9) 460 (77.6)
Hispanic, No. (%) 71 (14.2) 109 (19.0) 108 (18.2)
Other or not recorded, No. (%) 16 (3.1) 29 (5.0) 25 (4.2)
Co-occurring disorders (ICD-10 code)
Neoplasms (C00-D49) 46 (9.2) 90 (15.7) 81 (13.7)
Disorders of the blood and immune system (D50-D89) 123 (24.6) 164 (28.6) 185 (31.2)
Diabetes (E10, E11) 121 (24.2) 131 (22.9) 140 (23.6)
Obesity (E66) 57 (11.4) 68 (11.9) 47 (7.9)
Diseases of the circulatory system (I00-I99) 361 (72.2) 418 (73.0) 430 (72.51)
Diseases of the respiratory system (J00-J99) 335 (67.0) 404 (71.5) 421 (71.0)
Mood and anxiety disorders (F30-F48) 195 (39.0) 79 (13.8) 91 (15.4)
Other psychiatric disorders (F00-F29, F50-F99) 130 (26.0) 87 (15.2) 114 (19.2)
Diseases of the nervous system (G00-G99) 175 (35.0) 153 (26.7) 161 (19.2)
Observation time
Days under observation, median (IQR) 7 (4, 15) 7 (4, 15) 7 (4, 16)
Outcomes
Intubation or death composite, No. (%) 120 (24.0) 119 (20.7) 127 (21.4)
Death, No. (%) 101 (20.2) 87 (15.2) 102 (17.2)
Intubation 35 (7.0) 50 (8.7) 46 (7.8)

IQR, interquartile range.

a

Patients prescribed one or more antidepressant medications on admission (see text and Table 2 for details).

b

Frequency matched to antidepressant group by age, sex, and race/ethnicity.

c

Frequency matched to antidepressant group by age, sex, race/ethnicity, and “comparative health.”